Engineered Lactobacillus reuteri for scavenging reactive oxygen species and modulating oral microflora in periodontitis therapy

Abstract

The onset and progression of periodontitis are closely associated with subgingival dysbiosis and excessive localized oxidative stress. While some oral probiotics exhibit certain inhibitory effects on periodontitis-related pathogens, they often struggle to effectively colonize and antagonize these pathogens due to the complex oxidative stress at the site of periodontitis. In this study, we engineer Lactobacillus reuteri with a reactive oxygen species (ROS)-responsive adhesive polymer (phenylboric acid-dopamine-hyaluronic acid) (LR@PDH). In the periodontitis microenvironment, this polymer can consume ROS and then expose the phenolic hydroxyl group of dopamine, promoting the selective adhesion and colonization of Lactobacillus reuteri at the site of inflammation to antagonize pathogens. The results show that, compared to conventional probiotic therapy, inflammation-responsive adhesive Lactobacillus reuteri effectively alleviates local oxidative stress, reduces the abundance of pathogenic bacteria in the subgingival microbiome, and inhibits the progression of periodontitis. Additionally, its good biocompatibility and safety highlight its potential as a therapeutic approach for clinical treatment of periodontitis.

References

[1] Collaborators, GBDOD. Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2025, 405: 897-910

[2] Zhang Xet al.. The global burden of periodontal diseases in 204 countries and territories from 1990 to 2019. Oral. Dis., 2024, 30: 754-68

[3] Ximenez-Fyvie LA, Haffajee AD, Socransky SS. Comparison of the microbiota of supra- and subgingival plaque in health and periodontitis. J. Clin. Periodontol., 2000, 27: 648-57

[4] Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat. Rev. Dis. Prim., 2017, 3: 17038

[5] Bostrom L, Bergstrom J, Dahlen G, Linder LE. Smoking and subgingival microflora in periodontal disease. J. Clin. Periodontol., 2001, 28: 212-9

[6] Sczepanik FSCet al.. Periodontitis is an inflammatory disease of oxidative stress: we should treat it that way. Periodontol 2000, 2020, 84: 45-68

[7] Di Meo S, Reed TT, Venditti P, Victor VM. Role of ROS and RNS sources in physiological and pathological conditions. Oxid. Med. Cell Longev., 2016, 2016: 1245049

[8] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol., 2015, 15: 30-44

[9] Zhu XQet al.. Effects of porphyromonas gingivalis lipopolysaccharidetolerized monocytes on inflammatory responses in neutrophils. PLoS ONE, 2016, 11 e0161482

[10] Liu Cet al.. The role of reactive oxygen species and autophagy in periodontitis and their potential linkage. Front. Physiol., 2017, 8: 439

[11] Almerich-Silla JMet al.. Oxidative stress parameters in saliva and its association with periodontal disease and types of bacteria. Dis. Markers, 2015, 2015: 653537

[12] Wang Get al.. Smart gated hollow mesoporous silica hydrogel for targeting endoplasmic reticulum stress and promoting periodontal tissue regeneration. Adv. Sci., 2025

[13] Yu Y, Zhao X, Zheng Y, Xia D, Liu Y. Core-shell structured CeO(2)@ZIF-8 nanohybrids regulating the Ce(III)/Ce(IV) valence conversion to enhance ROS-scavenging capacity for periodontitis treatment. Biomaterials, 2026, 325: 123588

[14] Zhou S, Gravekamp C, Bermudes D, Liu K. Tumour-targeting bacteria engineered to fight cancer. Nat. Rev. Cancer, 2018, 18: 727-43

[15] Tang Yet al.. Engineered Bdellovibrio bacteriovorus: a countermeasure for biofilm-induced periodontitis. Mater. Today, 2022, 53: 71-83

[16] Huang QXet al.. Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota. Biomaterials, 2023, 301: 122274

[17] Wang Jet al.. Prophylactic supplementation with lactobacillus reuteri or its metabolite GABA protects against acute ischemic cardiac injury. Adv. Sci., 2024, 11: e2307233

[18] Wang Yet al.. Dual-functional probiotic hydrogel with puerarin integration for microbiota-neuroimmune regulation in antibiotic-free periodontitis therapy. Bioact. Mater., 2025, 53: 72-83

[19] Li Ket al.. Chairside live biotherapeutic hydrogel for comprehensive periodontitis therapy. Trends Biotechnol., 2025, 43: 408-32

[20] Teughels Wet al.. Clinical and microbiological effects of Lactobacillus reuteri probiotics in the treatment of chronic periodontitis: a randomized placebo-controlled study. J. Clin. Periodontol., 2013, 40: 1025-35

[21] Tekce Met al.. Clinical and microbiological effects of probiotic lozenges in the treatment of chronic periodontitis: a 1-year follow-up study. J. Clin. Periodontol., 2015, 42: 363-72

[22] Bullon P, Newman HN, Battino M. Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction?. Periodontol 2000, 2014, 64: 139-53

[23] Xie Yet al.. Cascade and ultrafast artificial antioxidases alleviate inflammation and bone resorption in periodontitis. ACS Nano, 2023, 17: 15097-112

[24] Luo HLet al.. Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable nanocoating. Mater. Today, 2023, 62: 98-110

[25] Anselmo AC, McHugh KJ, Webster J, Langer R, Jaklenec A. Layer-by-layer encapsulation of probiotics for delivery to the microbiome. Adv. Mater., 2016, 28: 9486-90

[26] Cao Z, Wang X, Pang Y, Cheng S, Liu J. Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment. Nat. Commun., 2019, 10 5783

[27] Zhou Det al.. Dopamine-modified hyaluronic acid hydrogel adhesives with fast-forming and high tissue adhesion. ACS Appl. Mater. Interfaces, 2020, 12: 18225-34

[28] Manjeu Jet al.. Evaluation of the reactive oxygen metabolite levels in plasma, gingival crevicular fluid, and saliva in generalized chronic periodontitis patients before and after nonsurgical periodontal therapy: a case-control and interventional study. J. Indian Soc. Periodontol., 2022, 26: 37-43

[29] Ozcan Eet al.. Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation. Clin. Oral. Investig., 2017, 21: 1113-21

[30] Li X, Wang X, Zheng M, Luan QX. Mitochondrial reactive oxygen species mediate the lipopolysaccharide-induced pro-inflammatory response in human gingival fibroblasts. Exp. Cell Res., 2016, 347: 212-21

[31] Alok Aet al.. Probiotics: a new era of biotherapy. Adv. Biomed. Res., 2017, 6: 31

[32] Kim Det al.. Mutanolysin-digested peptidoglycan of lactobacillus reuteri promotes the inhibition of porphyromonas gingivalis lipopolysaccharide-induced inflammatory responses through the regulation of signaling cascades via TLR4 suppression. Int. J. Mol. Sci., 2023, 25: 42

[33] Thierbach Ret al.. L. reuteri in supportive periodontal therapy-are there already clinical effects after 3 months with one lozenge a day? A double-blind randomized placebo-controlled study. Microorganisms, 2024, 12: 648

[34] Liu Yet al.. The influence of cell and substratum surface hydrophobicities on microbial attachment. J. Biotechnol., 2004, 110: 251-6

[35] Del Re B, Sgorbati B, Miglioli M, Palenzona D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol., 2000, 31: 438-42

[36] Piwat S, Sophatha B, Teanpaisan R. An assessment of adhesion, aggregation and surface charges of Lactobacillus strains derived from the human oral cavity. Lett. Appl. Microbiol., 2015, 61: 98-105

[37] Smith DE, Dhinojwala A, Moore FB. Effect of substrate and bacterial zeta potential on adhesion of mycobacterium smegmatis. Langmuir, 2019, 35: 7035-42

[38] Jiang X, Whitehead KA, Arneborg N, Fang Y, Risbo J. Understanding bacterial surface and adhesion properties and the implications for Pickering stabilization of colloidal structures. Curr. Opin. Colloid Interface Sci., 2024, 69: 101767

[39] Zhong Yet al.. The oral-gut-brain axis: the influence of microbes as a link of periodontitis with ischemic stroke. CNS Neurosci. Ther., 2024, 30 e70152

[40] Niu Yet al.. Blautia coccoides is a newly identified bacterium increased by leucine deprivation and has a novel function in improving metabolic disorders. Adv. Sci., 2024, 11 e2309255

[41] Abdulqadir R, Engers J, Al-Sadi R. Role of bifidobacterium in modulating the intestinal epithelial tight junction barrier: current knowledge and perspectives. Curr. Dev. Nutr., 2023, 7: 102026

[42] Guo Wet al.. Protective effects of a novel probiotic bifidobacterium pseudolongum on the intestinal barrier of colitis mice via modulating the Ppargamma/STAT3 pathway and intestinal microbiota. Foods, 2022, 11: 1551

[43] Yoshida Net al.. Bacteroides vulgatus and bacteroides dorei reduce gut microbial lipopolysaccharide production and inhibit atherosclerosis. Circulation, 2018, 138: 2486-98

[44] Huynh U, Zastrow ML. Metallobiology of lactobacillaceae in the gut microbiome. J. Inorg. Biochem., 2023, 238: 112023

[45] Punj A, Shenoy S, Kumari NS, Pampani P. Estimation of antioxidant levels in saliva and serum of chronic periodontitis patients with and without ischemic heart disease. Int. J. Dent., 2017, 2017: 1965697

[46] Bai Xet al.. An NIR-propelled janus nanomotor with enhanced ROS-scavenging, immunomodulating and biofilm-eradicating capacity for periodontitis treatment. Bioact. Mater., 2024, 41: 271-92

[47] Yang KMet al.. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria. Sci. Rep., 2021, 11 1631

[48] Wasfi R, Abd El-Rahman OA, Zafer MM, Ashour HM. Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans. J. Cell Mol. Med., 2018, 22: 1972-83

[49] Van Holm Wet al.. Antimicrobial potential of known and novel probiotics on in vitro periodontitis biofilms. NPJ Biofilms Microbiomes, 2023, 9 3

[50] Jansen PM, Abdelbary MMH, Conrads G. A concerted probiotic activity to inhibit periodontitis-associated bacteria. PLoS ONE, 2021, 16: e0248308

[51] Widyarman, A. S., Bachtiar, B. M. & Bahctiar, E. W. Reuterin isolated from Lactobacillus reuteri Indonesian strain affected Interleukin-8 and human beta defensin-2 on pathogens induced-HaCat cells. Trop. Life Sci. Res. 33, 75–90 (2022).

[52] Widyarman ASet al.. The potential of reuterin derived from Indonesian strain of Lactobacillus reuteri against endodontic pathogen biofilms in vitro and ex vivo. Saudi Dent. J., 2023, 35: 154-64

[53] Cui Z, Wang P, Gao W. Microbial dysbiosis in periodontitis and peri-implantitis: pathogenesis, immune responses, and therapeutic. Front. Cell Infect. Microbiol., 2025, 15: 1517154

[54] Yin Zet al.. Rational designs of biomaterials for combating oral biofilm infections. Adv. Mater., 2025, 37 e2305633

[55] Liu Y, Ai K, Lu L. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields. Chem. Rev., 2014, 114: 5057-115

[56] Liu Jet al.. Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases. Sci. Adv., 2022, 8 eabp8798

[57] Yi Set al.. Harnessing lactobacillus reuteri-derived extracellular vesicles for multifaceted cancer treatment. Small, 2025, 21 e2406094

[58] Han Net al.. Reuterin isolated from the probiotic Lactobacillus reuteri promotes periodontal tissue regeneration by inhibiting Cx43-mediated the intercellular transmission of endoplasmic reticulum stress. J. Periodontal Res., 2024, 59: 552-64

[59] Yang Fet al.. Single-tooth resolved, whole-mouth prediction of early childhood caries via spatiotemporal variations of plaque microbiota. Cell Host Microbe, 2025, 33: 1019-1032.e1016

[60] Mark Welch JL, Dewhirst FE, Borisy GG. Biogeography of the oral microbiome: the site-specialist hypothesis. Annu Rev. Microbiol., 2019, 73: 335-58

[61] Tang Yet al.. Erythrocyte-Mimicking nanovesicle targeting porphyromonas gingivalis for periodontitis. ACS Nano, 2024, 18: 21077-90

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82471018)

RIGHTS & PERMISSIONS

The Author(s)